Correlation of liver enhancement in gadoxetic acid –enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial
ConclusionsThe liver enhancement on the hepatobiliary phase of gadoxetic acid –enhanced MRI is correlated with biomarkers of liver functions in a multicenter cohort. However, this correlation shows variations between scanner brands.Key Points• The correlation between liver enhancement on the hepatobiliary phase of gadoxetic acid–enhanced MRI and liver function is consistent in a multicenter-multivendor cohort.• Signal intensity–based indices (liver-to-spleen ratio) can be used as an imaging biomarker of liver function.• However, absolute values might change between vendors.
Source: European Radiology - Category: Radiology Source Type: research
More News: Bilirubin | Cancer & Oncology | Carcinoma | Children | Hepatocellular Carcinoma | Laboratory Medicine | Liver | Liver Cancer | PET Scan | Radiology | Sodium | Study | Urology & Nephrology